尼沃卢马布在细胞癌中的安全性:一个案例报告
James Debono1, Dustin Balzan2, John Joseph Borg3
1Oncology Department, Sir Anthony Mamo Oncology Centre, Mater Dei Hospital, Msida, Malta.
概括
用于治疗癌症的尼沃卢马布 (Nivolumab) 可能会引起药物不良反应,如甲状腺功能低下症,肌溶解和肺炎. 这一案例凸显了尼沃卢马布的停用是由于疾病进展而不是这些副作用,并表明马耳他报告不足.
科学领域:
- 在瘤学瘤学.
- 药物监督 药物监督 药物监督
- 皮肤病学 皮肤病学
背景情况:
- 尼沃卢马布是一种用于治疗各种癌症的免疫疗法药物.
- 虽然尼沃卢马布一般耐受良好,但可能会引起药物不良反应 (ADRs).
- 细胞癌的治疗往往涉及基于疗效和安全性的疗法交换.
研究的目的:
- 报告一个与尼沃卢马布相关的多种药物不良反应病例.
- 为了评估这些事件的因果关系,使用Naranjo尺度.
- 调查马耳他尼沃卢马布相关的安全报告,并与病例调查结果进行比较.
主要方法:
- 一份病例报告显示,一名70岁的男性患者因细胞癌而接受尼沃卢马布治疗.
- 纳兰乔因果关系评估方法的应用,用于确定不良事件.
- 搜索了来自马耳他的nivolumab安全报告的EudraVigilance数据库.
主要成果:
- 在尼沃卢马布治疗期间,患者出现了甲状腺功能低下,肌溶解和肺炎.
- 纳兰乔的因果关系评估表明,甲状腺功能低下症和肺炎之间可能存在联系,可能存在结溶解.
- 在马耳他,只发现了六份尼沃卢马布报告,没有一个与案件事件相匹配,这表明潜在的报告不足.
结论:
- 尼沃卢马布可以引起多种药物不良反应,包括不那么常见的像阴茎溶解这样的副作用.
- 在这种情况下,停止尼沃卢马布治疗是由于疾病进展而不是不良事件.
- 在马耳他药监系统中,可能会出现不充分报告药物不良反应的情况.
更多相关视频
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
13.6K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:23Renal Clearance
The glomerular filtration rate (GFR) is a critical marker of kidney function, reflecting the efficiency of filtration by the glomeruli. Renal clearance of specific substances, such as inulin or creatinine, is commonly used to measure GFR.
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
01:06Renal Drug Clearance: Overview
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...